(Adds other Aussie medical cannabis firms)
** Australian medical cannabis firms extend gains, hover at
multi-month highs after the United Nations removed cannabis from
the most tightly controlled category of narcotic drugs
** Earlier this week, U.N. Commission on Narcotic Drugs
voted to remove cannabis from the most tightly controlled
category of narcotic drugs urn:newsml:reuters.com:*:nL8N2II573
** Auscann Group Holdings AC8.AX hits an over 6-month
high, BOD Australia BDA.AX soars 11.5% to its highest level
since July 2019 (https://bit.ly/33JNg8x)
** Creso Pharma CPH.AX hits its highest since Feb. 17 in
its seventh consecutive gain session, and is on track to post
its best week ever, climbing over 230%
** CPH says the U.N. decision will benefit its existing
global distribution network and foot print (https://bit.ly/2IdEJTM)
** Other ASX-listed pot stocks - Cann Group CAN.AX , Althea
Group Holdings AGH.AX , Elixinol EXL.AX are set for
double-digit weekly gains
(Reporting by Riya Sharma and Sameer Manekar in Bengaluru)
((Riya.Sharma@thomsonreuters.com;))